10 reports

EXECUTIVE SUMMARY ##.

  • Cancer
  • Lymphoma
  • APAC
  • World
  • Market Shares
  • VII. LYMPHOMA
  • Lymphoma Treatment Drugs Markets in China

Cytotoxic antibiotics and related drugs is one important Lymphoma Treatment Drugs in China.

  • Lymphoma
  • China
  • Shandong Luoxin Pharmacy Stock Co., Ltd.
  • Shenzhen Main Luck Pharmaceuticals Inc.
  • Zhejiang Hisun Pharmaceutical Co., Ltd.
  • LYMPHOMA TREATMENT DRUGS INDUSTRY ASSESSMENTS
  • LYMPHOMA TREATMENT DRUGS INDUSTRY ASSESSMENTS

Cytotoxic antibiotics and related drugs is one important Lymphoma Treatment Drugs in China.

  • Lymphoma
  • China
  • Beijing Wintic Pharma Co., Ltd
  • Pfizer Inc.
  • Shandong Luoxin Pharmacy Stock Co., Ltd.

The majority of the pipeline drugs in development are administered via the oral or intravenous routes, with only one product being tested in an intratumoral formulation.

  • Cancer
  • Lymphoma
  • Pathology
  • United States
  • World
  • JUN 25, 2018: IMMUNE DESIGN PRESENTS DATA ON THE MECHANISM OF ACTION OF G100 VIA TLR4 EXPRESSED IN B CELL MALIGNANCIES AT THE INAUGURAL AACR INTERNATIONAL MEETING ADVANCES IN MALIGNANT LYMPHOMA
  • PIPELINE BY MERCK & CO INC, H2 2019

Tissue inhibitor of metalloproteinase ## (TIMP-##) showed statistically significant reduction; mean change of TIMP-##, -##. ## IU, P=##. ##.

  • Hospital
  • Immunotherapy
  • Lymphoma
  • Therapy
  • TaiwanJ Pharmaceuticals Co., Ltd.
  • PIPELINE BY ASCENTAGE PHARMA GROUP CORP LTD, H2 2019
  • PIPELINE BY ASTRAZENECA PLC, H2 2019

By using E mu-Myc lymphoma cells lacking p##, it was showed that CR mimetics such as ##-deoxyglucose led to a decrease in Mcl-## expression and sensitized lymphoma cells to ABT-##-induced death independently of p##.

  • Lymphoma
  • Therapy
  • United States
  • Product Initiative
  • AbbVie Inc.
  • VACCINE FOR COLON CARCINOMA AND LYMPHOMA - DRUG PROFILE
  • PRODUCTS UNDER INVESTIGATION BY UNIVERSITIES/INSTITUTES, H2 2019

Eighty-one percent (##/ ##) had = ## positive immunogenicity assay.

  • Cancer
  • Lymphoma
  • Therapy
  • United States
  • Product Initiative
  • PIPELINE BY AURIGENE DISCOVERY TECHNOLOGIES LTD, H2 2019
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY INDICATION, H2 2019

The drug candidate acts by targeting interleukin ## receptor-associated kinase ##(IRAK##) and interleukin ## receptor-associated kinase ##(IRAK##).

  • Lymphoma
  • Pharmaceutical
  • United States
  • World
  • Product Initiative
  • MAR 22, 2013: ROCHE RECEIVES CHMP POSITIVE OPINION FOR MABTHERA
  • FEATURED NEWS & PRESS RELEASES

The molecules developed by Companies in Pre-Registration, Filing rejected/ Withdrawn, Phase III, Phase II and Preclinical stages are ##, ##, ##, ## and ## respectively.

  • Lymphoma
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative

The molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are ##, ##, ##, ## and ## respectively.

  • Lymphoma
  • Personality Disorder
  • Therapy
  • United States
  • Product Initiative